Omega Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Omega Therapeutics generated cash of -$91,510,000, which is more than the previous year. Cash used in financing activities reached the amount of $41,823,000 last year. Net change in cash is therefore -$2,172,000.
Cash Flow
| 2019 | -15.67M | -885K | 11.98M |
|---|---|---|---|
| 2020 | -26.13M | -1.80M | 48.61M |
| 2021 | -57.60M | -40.39M | 261.53M |
| 2022 | -98.51M | -18.06M | 708K |
| 2023 | -91.51M | 47.51M | 41.82M |
OMGA Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 70.95M | 186.82M | 23.29M | 2.61M | 7.19M |
Operating activities | |||||
Net income | -97.42M | -102.70M | -68.28M | -29.44M | -17.94M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 6.77M | 5.19M | 1.38M | 1.14M | 794K |
Stock-based compensation expense | 8.79M | 7.75M | 3.18M | 637K | 335K |
| Deferred income tax benefit | 8.79M | 7.75M | 3.18M | 637K | 335K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -5.51M | -362K | -257K | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.48M | 985K | 1.04M | 138K | 671K |
Cash generated by operating activities | -91.51M | -98.51M | -57.60M | -26.13M | -15.67M |
Investing activities | |||||
Purchases Of Investments | -19.76M | -57.41M | -38.93M | 0 | 0 |
Investments In Property Plant And Equipment | -2.86M | -1.38M | -1.46M | -1.80M | -885K |
Acquisitions Net | 0 | 16.68M | 0 | 0 | 0 |
Cash generated by investing activities | 47.51M | -18.06M | -40.39M | -1.80M | -885K |
Financing activities | |||||
Common Stock Issued | 40M | 708K | 131.23M | 48.61M | 8M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 1.62M | 0 | -8M | 0 | 4M |
Cash used in financing activities | 41.82M | 708K | 261.53M | 48.61M | 11.98M |
Net Change In Cash | -2.17M | -115.86M | 163.53M | 20.67M | -4.57M |
Cash at end of period | 68.78M | 70.95M | 186.82M | 23.29M | 2.61M |
| Data source | Data source | Data source |